Alergia e Imunologia
Breve revisão | Avanços na dermatite atópica.
12 Ago, 2021 | 11:52hAdvances in atopic dermatitis – Clinical Medicine Journal
Estudo randomizado PRINCIPLE | Budesonida inalatória melhora o tempo de recuperação da COVID-19 em pessoas com alto risco de complicações na comunidade.
11 Ago, 2021 | 11:02hComentário convidado: The use of inhaled corticosteroids in early-stage COVID-19
M-A | Mais de 50 efeitos de longo prazo da COVID-19.
11 Ago, 2021 | 10:57hConteúdos relacionados:
Cohort study: Risk factors for long covid in previously hospitalized children.
Viewpoint: The road to addressing Long Covid.
Review: Long covid—mechanisms, risk factors, and management.
Review: Symptoms, complications and management of long COVID.
Studies elucidate poorly understood long COVID.
Long Covid: Half of young adults with COVID-19 have persistent symptoms 6 months after, study finds.
[Preprint] Long Covid: Third of people infected have long term symptoms.
Almost 25% of COVID-19 patients develop long-lasting symptoms, according to a new report.
Perspective | The four most urgent questions about long COVID.
Systematic review: Frequency, signs and symptoms, and criteria adopted for long COVID-19.
Report: 376,000 people in UK have had long Covid symptoms for at least a year.
One third of patients hospitalized with COVID-19 have lung changes after a year
Perspective | They Tested Negative for Covid. Still, They Have Long Covid Symptoms.
Cohort study: One in ten have long-term effects 8 months following mild COVID-19
Long Covid Implications for the workplace
Long Covid in the UK – More than a million affected in February, survey suggests
Covid-19: Middle aged women face greater risk of debilitating long term symptoms
Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers”
Review | Post-acute COVID-19 syndrome
Long Covid | Four-month clinical status of a cohort of patients after hospitalization for COVID-19
Perspective | Long Covid isn’t as unique as we thought
Attributes and predictors of long COVID
WHO Report: Preparing for Long COVID 2021
Long Covid: Sequelae in adults at 6 Months after COVID-19 infection
How many people get ‘long COVID’ – and who is most at risk?
Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline
Patients, clinicians seek answers to the mystery of ‘Long COVID’
Long Covid: 6-month consequences of COVID-19 in patients discharged from hospital
NICE Guideline: Managing the long-term effects of COVID-19
Comentário no Twitter
Nuestro estudio sobre Covid 🦠Persistente o de Largo recorrido se ha publicado finalmente en @SciReports
👉https://t.co/ATFO5QO3kF pic.twitter.com/qwBikXyqll— Sonia Villapol (@svillapol) August 10, 2021
[Preprint] Estudo randomizado fase 1/2 | Uma dose de reforço é imunogênica e será necessária para idosos que completaram o esquema de duas doses com CoronaVac.
10 Ago, 2021 | 12:44h
Comentário no Twitter
6-month follow-up of people aged 60+ in early trials of Sinovac's CoronaVac in China. Authors conclude antibodies dropped too far, but a booster dose improved signs of immunity https://t.co/ooQ5M9gJZC (Preprint)
— Hilda Bastian, PhD (@hildabast) August 9, 2021
Dermatoses autoimunes bolhosas: características clínicas, avaliação diagnóstica e opções de tratamento.
10 Ago, 2021 | 12:18hBullous Autoimmune Dermatoses – Deutsches Ärzteblatt International
Estudo randomizado | Segurança e imunogenicidade de esquemas de segunda dose heterólogos vs. homólogos de vacinas contra COVID-19 com vetor adenoviral vs. de mRNA.
9 Ago, 2021 | 11:40hComentário convidado: Optimising SARS-CoV-2 vaccination schedules – The Lancet
Conteúdo relacionado: Another study shows increased immune response with heterologous Oxford-AstraZeneca/mRNA vaccination (vários artigos sobre o tema)
Comentário no Twitter
Just published @TheLancet
A randomized mix and match trial of AZ and Pfizer vaccination in >800 people shows that mixing is safe and can engender at least as good, if not better, immune response https://t.co/V40Dy59Ia8 by @XinxueLiu and colleagues pic.twitter.com/tKl59LFz4i— Eric Topol (@EricTopol) August 6, 2021
Estudo do CDC mostrou um risco reduzido de reinfecção por SARS-CoV-2 após vacinação contra Covid-19.
9 Ago, 2021 | 11:37h
Comentários no Twitter
This is non randomized. The two biases are:
1. Behavior among those who got vaccinated likely different than those who don't
2. Likely those who didn't tested more aggressively
I would not cite this as many are doinghttps://t.co/rSkBC37uq0
— Vinay Prasad, MD MPH 🎙️📷 (@VPrasadMDMPH) August 7, 2021
Study shows that full #COVIDVaccination ⬇️ likelihood of being re-infected with #COVID19 compared to those who were previously had COVID but were not vaccinated (risk ⬆️ 2.3 fold)#GetVaccinated even if you have had COVID previouslyhttps://t.co/3dF3XPxwYp@fascinatorfun pic.twitter.com/ip6zTvNN86
— Kamlesh Khunti (@kamleshkhunti) August 7, 2021
Reforços da vacina contra COVID: questões mais importantes.
9 Ago, 2021 | 11:30hCOVID vaccine boosters: the most important questions – Nature
Comentário no Twitter
I agree with @nataliexdean: “We just don’t have clear evidence of enough of a loss of efficacy to change our focus or distract from the main goal, which is trying to get as many people first doses” as possible." https://t.co/FEKB4vg0Dz
— Sanghyuk Shin (@sanghyuk_shin) August 6, 2021
Mais dados mostram que uma dose da vacina da Pfizer pode ser suficiente para pessoas que já tiveram COVID.
9 Ago, 2021 | 11:29hComentário: One Dose of Pfizer Vaccine May Be Enough for Folks Who’ve Had COVID – HealthDay
Estudo original: SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine – JAMA Network Open
Conteúdos relacionados:
Perspective | Is one vaccine dose enough if you’ve had COVID? What the science says.
Another study shows a single dose of mRNA vaccine may be enough for patients with previous Covid-19
Spain to give just one vaccine dose to under 55-year olds who had COVID-19
Perspective: Is one vaccine dose enough after COVID-19 infection?
France’s health authority recommends single vaccine shot for people who have had COVID-19
Covid-19: People who have had infection might only need one dose of mRNA vaccine
Comentário no Twitter
SARS-CoV-2 Antibody Responses After 1 and 2 Doses of the BNT162b2 Vaccine https://t.co/ARMdH8Yboo via @JAMANetworkOpen part of @JAMANetwork Small study but one that confirms the policy of many European countries in which one dose of vaccine is sufficient after having COVID.
— Carlos del Rio (@CarlosdelRio7) August 7, 2021